Target Market Small-scale blood testing innovator serving blood banks and hospitals with a rapid diagnostic system. Focus on institutions prioritizing transfusion reduction and patient safety presents a clear entry point for early pilots and strategic partnerships.

Fast Decision Product claims rapid approximately 10 minute assessment comparing therapies. Position as a time-saving, cost-reducing tool to differentiate from slower coagulation analyzers, enabling sales conversations around workflow efficiency and improved outcomes.

Strategic Partner Existing contract manufacturing partnership with Enercon Technologies Inc. indicates openness to OEM/scale collaborations. Leverage to propose co-development, manufacturing scalability, and regional deployments to accelerate market reach.

Funding Gap Revenue under $1M with seed funding of $790K suggests early-stage needs for field trials, regulatory navigation, and sales team expansion. Opportunities exist to propose joint funding opportunities, grants, or customer-funded pilots to validate ROI.

Competitive Positioning Compared to large incumbents with extensive sales forces, this agile, small team can offer personalized support, rapid iteration, and faster deployment. Target mid-size hospitals and regional distributors seeking nimble partnerships and faster time-to-market.